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ReviewFunctionalized Synthetic Biodegradable
Polymer Scaffolds for Tissue EngineeringXiaohua Liu, Jeremy M. Holzwarth, Peter X. Ma*Scaffolds (artificial ECMs) play a pivotal role in the process of regenerating tissues in 3D.
Biodegradable synthetic polymers are the most widely used scaffolding materials. However,
synthetic polymers usually lack the biological cues found in the natural extracellular matrix.
Significant efforts have been made to synthesize biode-
gradable polymers with functional groups that are used to
couple bioactive agents. Presenting bioactive agents on
scaffolding surfaces is the most efficient way to elicit
desired cell/material interactions. This paper reviews
recent advancements in the development of functionalized
biodegradable polymer scaffolds for tissue engineering,
emphasizing the syntheses of functional biodegradable
polymers, and surface modification of polymeric scaffolds.1. Introduction
As a multi-disciplinary field, tissue engineering integrates
materials science with regenerative medicine by applying
the principles of engineering and biology to clinical
issues.[1] A typical tissue engineering strategy can be
separated into three components: a scaffold [an artificial
extracellularmatrix (ECM)], cells, andbiological factors. TheX. Liu, Dr. P. X. Ma
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plays a pivotal role in cell adhesion, proliferation,
differentiation, and new tissue formation in three dimen-
sions (3D). Ideally, a scaffold should be designed to possess
the following characteristics: (i) a biocompatible and
biodegradable substrate with controllable degradation
rates; (ii) a 3D and highly porous architecture to accom-
modate cell attachment, penetration, proliferation, and
ECM deposition; (iii) an interconnected pore network to
facilitate nutrient and waste exchange; (iv) a suitable
mechanical strength to support regeneration; and (v) a
proper surface chemistry and surface topography to
promote cellular interactions and tissue development.[2,3]
With the advancement of developmental biology and
nanotechnology, recent research on scaffolding has more
focused on the design and synthesis of functionalized
scaffolds that canelicit desirable cell/material interactions to
guide cell behavior and enhance new tissue formation.[4–8]
Scaffolds can be produced from a variety of materials,
including metals, ceramics, and polymers. Metallic alloys
are popular for both dental and bone implants[9] while
ceramics with good osteoconductivity have been used forelibrary.com DOI: 10.1002/mabi.201100466 911
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X. Liu, J. M. Holzwarth, P. X. Mabone tissue engineering.[10] However, both metals and
ceramics have significant drawbacks. Metals are not
biodegradable and do not provide a biomimetic matrix
for cell growth and tissue formation. Ceramics also have
limited biodegradability and are difficult to process into
highlyporousstructuresdueto theirbrittleness. Incontrast,
polymers have great processing flexibility and their
biodegradability can be imparted through molecular
design. Therefore, polymers are dominant scaffolding
materials in tissue engineering. In general, naturally
derived polymers have the potential advantage of biolo-
gical recognition that may positively support cell adhesion
and function. However, complexities associated with
natural polymeric materials, including complex structural
composition, purification, immunogenicity, and pathogen
transmission, have driven the development of synthetic
polymers for use as scaffolding materials. Synthetic
polymers have a higher degree of processing flexibility
and no immunological concerns compared to natural ECM
proteins. By incorporating bioactive agents into synthetic
polymers, functionalized scaffolds that combine the
advantage of both synthetic and natural polymeric
materials can be fabricated.
This paper covers the design and fabrication of functio-
nalized biodegradable polymer scaffolds, focusing on the
synthesis of functional biodegradable polymers and the
surface modification of polymeric scaffolds. Selected
examples from both our and other groups are presented
for the purpose of illustration. Additionally, the cellular
response on functionalized scaffolds will be briefly
discussed. Since the methods of scaffolding fabrication
and incorporation of growth factors into scaffolds have
been extensively reviewed in detail elsewhere,[2,3,11–18]
they will not be the focus of this paper.
the American Institute of Medical and Biological
Engineering (AIMBE) and a Fellow of Biomater-
ials Science and Engineering (FBSE).2. Synthesis of Functional Biodegradable
Polymers
Poly(a-hydroxyacids), including poly(glycolic acid) (PGA),
poly(lactic acid) (PLA), and their copolymer poly[(lactic
acid)-co-(glycolic acid)] (PLGA), are the most widely used
synthetic polymeric materials in tissue engineering.[19]
Thesepolymersarewell characterizedandhavegainedFDA
approval for certain human use (e.g., sutures). Poly(a-
hydroxyacids) have been fabricated into 3D scaffolds via a
number of techniques. For example, poly(L-lactic acid)
(PLLA) has been fabricated into nano-fibrous scaffolds to
mimic the physical architecture of natural collagen (amain
component of ECM).[20] The nano-fibrous PLLA scaffolds
have been demonstrated to enhance cell adhesion and
differentiation.[21,22] However, there are no functional
groupsavailableon thepoly(a-hydroxyacids) chains,which
limits the capacity to incorporate biologically activeMacromol. Biosci. 20
 2012 WILEY-VCH Verlag Gmbmoieties onto the scaffolding surface. Considerable efforts
have been made to improve the functionality of these
polymers to further expand their applications.[2–5,23] One
strategy is to copolymerize the a-hydroxyacids with other
monomers containing functional pendant groups such as
amino and carboxyl groups. In one study, L-lactide and (RS)-
b-benzyl malate were copolymerized by ring-opening
polymerization, and poly{(L-lactide)-co-[(RS)-b-malic acid]}
with pendant carboxyl groups was obtained by removing
the benzyl groups.[24] Leemhuis et al. synthesized two
functionalized dilactones (benzyloxymethylmethyl glyco-
lide and benzyloxymethyl glycolide) with protected hydro-
xyl groups, which were then copolymerized with L-
lactide.[25] Deprotection of the benzyloxymethyl groups
gave the corresponding hydroxylated PLLA copolymers.
Noga et al. furthermodified thependant hydroxyl groupsof12, 12, 911–919
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correspondingcarboxylicacid functionalizedcopolymers to
attach amine-containing biological molecules.[26] Chen et
al. synthesized two cyclic carbonate monomers (acryloyl
carbonate and methacryloyl carbonate), which were
copolymerized with D,L-lactide to incorporate acryloyl
groups in the copolymers.[27] The acryloyl groups were
amenable to the Michael-type addition reaction with
varying thiol-containing molecules such as arginine-
glycine-aspartic acid-cysteine (RGDC) peptide under mild
conditions. Kimura et al. synthesized a cyclic diester
monomer consisting of glycolate and benzyl a-L-malate
units and copolymerized it with L-lactide to obtain
biodegradable polymers with carboxyl groups.[28,29] Lan-
ger’s group synthesized poly[(L-lactic acid)-co-(L-lysine)]
with functional lysine residue, which was further coupled
with RGD peptide.[30,31]
Although the copolymerization of lactide/glycolide with
other monomers is effective to generate functional groups
in the random copolymers, this method often changes the
physical properties (e.g., crystallinity and mechanical
strength) of the initial homopolymers as well. To address
this, anumberofpoly(a-hydroxyacid)-basedblockandgraft
copolymers have been designed and synthesized.[32–38]
Poly(ethyleneglycol) (PEG) is themostwidelyusedsegment
that has been introduced to the poly(a-hydroxyacids).
Diblock, triblock, andmultiblock copolymers of PL(G)A/PEG
have been synthesized conveniently by ring-opening
polymerization of lactide/glycolide in the presence of
PEG and selected catalysts.[39–44] However, the functional
groups (hydroxyl or carboxyl groups) in PEG-containing
block copolymers can only be found at the end of each PEG
segment, and their content in these block copolymers is
very low, which limits subsequent chemical modification.
A few non-PEG block and graft copolymers have been
reported.[45–50] Our group recently designed and synthe-
sized a series of biodegradable amphiphilic poly[hydrox-
yalkyl (meth)acrylate]-graft-poly(L-lactic acid) (PHAA-g-
PLLA) copolymers.[51] These copolymers contain pendant
hydroxyl groups in the copolymer chains and have been
successfully fabricated into 3D nano-fibrous scaffolds.
Biomimetic scaffolds made from these copolymers can be
further functionalized, are more hydrophilic, and have
faster degradation rates than the PLLA homopolymer,
which are advantageous for certain tissue engineering
applications.
Poly(e-caprolactone) (PCL) isanotherpoly(a-hydroxyacid)
that has been used for tissue engineering applications.
Similar strategies were utilized to incorporate functional
groups into PCL chains.[52–56] For instance, functionalized
PCL copolymers were synthesized by copolymerization
of e-caprolactonewitha-chloro-e-caprolactone, followedby
atom transfer radical addition to incorporate pendant
hydroxyl, carboxyl, and epoxide groups.[52] The pendantwww.MaterialsViews.com
Macromol. Biosci. 20
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by copolymerization of e-caprolactone with another
monomer, 5-ethyleneketal-e-caprolactone, followed by a
deacetylization step to reduce the ketone groups into
hydroxyl groups.[57] The syntheses of these functional co-
monomers, as well as the de-protection process, however,
are often complex and tedious.
Other synthetic biodegradable polymers, including
poly(3-hydroxybutyrate) (PHB),[58] polyurethanes (PU),[59,60]
polycarbonate (PC),[61] poly(ortho ester) (POE),[62] poly(pro-
pylene fumarate) (PPF),[63] and polyphosphazenes (PP),[64]
havealso beenusedasa scaffoldingbiomaterials.However,
there are significantly fewer reports of functionalizing
these biomaterials compared to the poly(a-hydroxyacids).
Some of the examples include the syntheses of functiona-
lized PC.[65–67] For instance, pendant amino groups were
incorporated into PC chains by polymerization of the cyclic
carbonate monomer, (2-oxo-[1,3]-dioxan-5-yl)carbamic
acid benzyl ester, followed by removal of the protective
benzyloxycarbonyl groups.[56] Further functionalization of
the pendant amino groups was demonstrated by grafting
with RGD peptides. Because this reaction route involves
multiple steps, the synthetic efficiency should be consid-
ered.
Synthetic polypeptides are emerging as a class of
appealing functional biomaterials due to their unique
physical, chemical, and biological properties.[68] A good
example is the peptide amphiphiles (PAs) designed by
Stupp and coworkers.[69,70] These PAs have five specific
structural features: (i) a long alkyl tail that conveys
hydrophobic character to the molecule and makes the
molecule amphiphilic; (ii) four consecutive cysteine resi-
dues that form disulfide bonds to stabilize the structure;
(iii) a linker region of three glycine residues to provide the
hydrophilic head group the flexibility from the rigid cross-
linked region; (iv) a phosphorylated serine residue that
interacts strongly with calcium ions intended to enhance
mineralization; and (v) an RGD peptide to aid in cell
adhesion.[70] The PAs have been shown to self-assemble
into nano-fibrous networks when the strong electrostatic
repulsion between molecules is neutralized either by
changing pH or by adding divalent ions. Furthermore,
the amphiphilic nature of the molecules allows the
specific presentation of hydrophilic peptide signals on
the surfaces of the assembled nano-structures. However,
like many other hydrogel materials, the formation of
mechanically stable 3D geometry from these PAs needs to
be addressed.
Incorporation of proteinase-sensitivemotifs into bioma-
terials is an exciting approach to prepare cell-responsive
functional biomaterials.[7] Hubbell and coworkers provided
a good example of engineering synthetic PEG-based
hydrogels as cell-ingrowth matrices for tissue regenera-
tion.[71,72] The hydrogel networks contain pendant oligo-12, 12, 911–919
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X. Liu, J. M. Holzwarth, P. X. Mapeptides (RGDSP) for cell adhesion and matrix metallopro-
teinase (MMP) -sensitive peptides as crosslinkers for the
PEG chains. The MMP-sensitive crosslinker determines the
response of the material in the presence of cell-secreted
MMPs. Therefore, this PEG-based hydrogel is a cell-
responsive functional biomaterial. The authors further
demonstrated that suchgels are suitablematrices todeliver
recombinant human bone morphogenetic protein-2
(rhBMP-2) and to induce bone regeneration.3. Surface Modification of 3D Polymer
Scaffolds
Generally, bioactive agents can be incorporated onto
functionalized scaffolds through bulk or surface modifica-
tion. In the bulk modification process, bioactive agents are
coupled with functional polymers prior to scaffold fabrica-
tion. For example, the RGD peptide was first chemically
attached to the lysine residue of poly[(L-lactic acid)-co-(L-
lysine)] before scaffold preparation.[31] The RGD peptide,
therefore, was distributed both on the surface and in the
bulk of the poly[(L-lactic acid)-co-(L-lysine)] scaffold. Since
cell/material interactions take place on scaffold surfaces,
the bioactive molecules encapsulated inside the scaffold
will not be able to interact with cells. Therefore, bulk
modification is not an efficient way to incorporate
bioactive agents. Furthermore, bulk modification often
alters the mechanical and processing properties of the
scaffold. In contrast, surface modification only presents
bioactive agents on a scaffold surface; therefore, it can
overcome the above limitations. In fact, this strategy has
become increasingly attractive to prepare functional
scaffolds.[73–77]
A number of surface modification methods have been
developed to incorporate bioactive molecules onto the
scaffold surface. A physical adsorption technique was
reported to modify PLGA (75/25) scaffolds with either
fibronectin or cell-adhesion motif RGD.[78] While this
surface coating process is simple, its efficiency is low and
it has little control over the stability of the modified layer.
Partial hydrolysis is a simple way to produce a certain
amount of hydroxyl/carboxyl groups on the scaffold
surface.[79–81] For example, poly(D,L-lactic acid) (PDLLA)
was treated under strong alkaline conditions to introduce
hydroxyl groups, which were further used to graft
chitosan.[82] This method, however, is technique sensitive,
and the hydrolysis also alters the surface morphology and
bulk mechanical properties. Chemical vapor deposition
(CVD) was originally developed to deposit thin films on
solid substrates.[83–85] This technique has recently been
utilized to prepare surface-modification layers on the
scaffold surface.[86–88] For instance, poly[(4-amino-p-xylyl-
ene)-co-(p-xylylene)] was deposited on PCL surfacesMacromol. Biosci. 20
 2012 WILEY-VCH Verlag Gmbthrough CVD polymerization to provide a reactive amine
layer on the substrate surface.[87] Biotin was then
conjugated on the modified PCL surface to immobilize
avidin for binding of biotinylated adenovirus. The biocom-
patibility of deposited poly[(4-amino-p-xylylene)-co-(p-
xylylene)], however, has to be seriously considered. Plasma
exposure is an effective procedure for surface etching.
Oxygen plasma treatment was used to incorporate hydro-
xyl and peroxyl groups onto PLGA and PDLLA films.[89,90]
However, it has been reported that this plasma etching
process alters both surface chemistry and surfacemorphol-
ogy, which leads to the difficulty to predict how cells will
respond on this surface-modified material.[89] Plasma
exposure has also been utilized to incorporate other
functional groups on polymer backbones.[91] For instance,
Nitschke et al. utilized low pressure ammonia plasma
treatment for the modification of PHB thin films.[92] The
introduction of amine function was used for subsequent
protein immobilization. The plasma treatment of PHB
induced a durable conversion from a hydrophobic into a
hydrophilic surface without significantly altering the
morphology. Cheng and Teoh reported an argon plasma
treatment for the modification of PCL thin films.[93] The
pretreated films were UV polymerized with acrylic acid
prior to immobilization of collagen. Because of the limited
plasma penetration, this method can only be used for two-
dimensional (2D) films or very thin 3D structures.
As discussed above, most of the surface modification
techniques in the literature have been focusing on the
modification of 2D films or very thin 3D constructs, and are
limited for a 3D scaffold with designated structure and
morphology. In our group, several effective techniques,
including molecular entrapment and self-assembly, have
been developed to modify the internal pore surfaces of 3D
porous polymer scaffolds.[94–97] For example, we developed
a surface-entrapment technique to incorporate biomole-
cules (e.g., gelatin) onto the scaffold surface.[94] The
essential point of this technique was the selection of a
suitable solvent system such that biomolecules were
soluble in the solvent mixture, while the scaffold swelled
butdidnotdissolve in the solventmixture.Asanon-solvent
of the scaffold was added, the scaffold surface quickly
shrank, leading to the entrapment of biomolecules on the
surface of the scaffold. Compared with simple surface
coating, the entrapped biomolecules were stable and did
not dissolvewhen rinsed inwater or aqueous tissue culture
medium. No functional groups on the scaffold surfaces are
needed for this surface modification method as long as
proper solvent system is selected. In addition, the entrap-
ment method can be used for any geometry, morphology,
and thickness of 3D scaffold, which is a limitation formany
other surface modification methods.
By integrating surface-entrapment into the scaffolding
fabrication process, a porogen-induced surface modifica-12, 12, 911–919
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Figure 1. Surface modification of a 3D nano-fibrous PLLA with
gelatin. TRITC-labeled gelatin was utilized to visualize the attach-
ment and distribution of gelatin on the scaffold surface. (a) A
photograph shows the overview of the scaffold before (I) and
after surface modification (II); (b) a confocal image shows the
distribution of gelatin on the outermost surface after surface
modification; (c) a confocal image shows the distribution of
gelatin in the center of the scaffold after surface modification.
From Liu et al.,[107] 2009 by Springer.
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www.mbs-journal.detion technique has been developed to prepare biomimetic
nano-fibrous PLLA scaffolds.[95] In this one-step process, the
modifying agent also acts as the porogen for the scaffold
fabrication. Therefore, the surface modification is accom-
plishedduring the scaffoldpreparation.Gelatinwasusedas
an example of a surface modification agent. First, gelatin
spheres were fabricated and assembled into a 3D negative
replica of the PLLA scaffold. The PLLA solution in water/
tetrahydrofuran (THF)mixturewas then cast on the gelatin
spheres template. The introduction of the solvent mixture
in the PLLA solution was to ensure that certain amounts of
gelatinmolecules couldbeentrappedonto thesurfaceof the
PLLA scaffolds during the phase separation process. After
phaseseparationandporogen removal, anano-fibrousPLLA
scaffold was generated with an interconnected spherical
pore network, and its surface was modified with a layer of
gelatin molecules.
Electronic layer-by-layer self-assembly has been widely
used to prepare well-defined multilayer films.[98] This
process has recently beenutilized to prepare functionalized
scaffold surfaces in our group.[96] In a typical process, the
pretreated nano-fibrous PLLA scaffold was activated in an
aqueous poly(diallyldimethylammonium chloride) (PDAC)
solution to obtain a positively charged surface. After
washing with water, the scaffold was subsequently
immersed in a solution of negatively charged biomacro-
molecules (e.g., gelatin). Further growth of the PDAC/
gelatin bilayers was accomplished by repeating these
procedures. To visualize the attachment of gelatin on the
nano-fibrous scaffold surface, tetramethylrhodamine iso-
thiocyanate (TRITC)-labeled gelatin was added in the self-
assembly solution. Development of color on the scaffold
after the self-assemblyprocess showed that thegelatinwas
successfully incorporated on thenano-fibrous PLLA scaffold
surface (Figure 1a). Confocal images further confirmed that
gelatin was distributed evenly throughout the entire
scaffold surface (Figure 1b and c). This self-assembly
technique has a high degree of molecular control over
surface chemistry, coating thickness, and maintenance of
the 3D scaffold architecture. Moreover, the use of aqueous
solutions makes it easy to carry out. Therefore, it is an
appealing surface modification method for 3D scaffolds
with complex geometry as long as the scaffold pores are
interconnected.
In order to mimic both the physical architecture and
chemical composition of natural extracellular bonematrix,
a biomimetic process that allows in situ apatite formation
on the internal surfaces of the pore walls of nano-fibrous
gelatin scaffolds was developed using a simulated body
fluid (SBF) technique.[97] A large number of nano-featured
bone-likeapatitemicroparticlesweregrownonthe internal
surfaces of nano-fibrous gelatin scaffolds after 7 d of
incubation (Figure 2c and d). Control over the particle size
and their coverage of the pore surfaces was achieved bywww.MaterialsViews.com
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tion, incubation time, and pH value of the solution.
Generally, a longer incubation time of the NF-gelatin
scaffold led tomore apatite formation (Figure 2e). However,12, 12, 911–919
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Figure 2. SEM images of nano-fibrous gelatin scaffolds with surface modification of
apatite particles. The apatite microparticles were prepared by incubated in 1.5 SBF for
varying times. (a) 1 d overview; (b) 1 d pore/wall structure; (c) 7 d overview; (d) 7 d pore/
wall structure; (e) 21 d overview; (f) 21 d pore/wall structure. From Liu et al.,[97]2009 by
Elsevier.
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X. Liu, J. M. Holzwarth, P. X. Mathe interconnected macroporous structure of the scaffolds
was still maintained, which is important for cell migration
and mass transport when used for tissue regeneration. In
addition to the aimed surface chemical modification for
improved osteoconductivity, the mechanical properties of
the surface-modified nano-fibrous gelatin scaffolds were
also significantly improved compared to the plain gelatin
scaffolds.4. Cell Response on Functionalized Scaffolds
Functionalizingthescaffoldwithcarboxylicacidgroupshas
shown promise by making the surface more hydrophilic.
Fibroblasts seeded on carboxylic acid modified PGA, PLGA,
and PLLA scaffolds were spread over a larger area and had
higher adhesion and proliferation rates compared to
unmodified scaffolds.[99] Incorporation of hydroxyapatite
(HA) into scaffolds has been shown to significantly increaseMacromol. Biosci. 2012, 12, 911–919
 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheosteoblast adhesion and proliferation
compared to pure PLLA scaffolds.[100]
As discussed above, a more reliable
method to functionalize scaffolds is to
use bioactive molecules derived from
natural ECM proteins. For instance, gela-
tin, a denatured form of collagen, was
used to modify the surfaces of 3D PLLA
scaffolds.[95,96] The presence of gelatin
greatly increased the adherence, prolif-
eration, and spreading of MC3T3-E1 cells
and more collagen fibers and other cell
secretionswere deposited on the surface-
modified scaffolds than on the control
scaffolds (Figure 3).[94] More specific than
gelatin, peptide fragments have been
used to tailor cell adhesion and growth.
TheRGDpeptide is ubiquitous in the ECM
andpromotes cell adhesion by acting as a
binding site for integrins.[101,102] PCL
films modified with RGD served to
promote the attachment and spreading
of mesenchymal stem cells (MSCs).[101]
RGD may increase focal adhesion kinase
(FAK) phosphorylation for integrin-based
signal transduction, which could play a
role in cell proliferation and viability.[103]
In addition to adhesion and prolifera-
tion, functionalized scaffolds can be used
to direct cell differentiation. The incor-
poration of HA on gelatin scaffolds was
used to study the differentiation of
MC3T3-E1 preosteoblasts into osteo-
blasts.[97] Cells were seeded on gelatinscaffolds with and without HA for 4 weeks and two
osteogenicmarkers [bonesialoprotein (BSP)andosteocalcin
(OCN)] were examined. Results showed that levels of BSP
andOCNwerefiveandtwotimeshigher, respectively, in the
gelatin-HA scaffolds compared to the gelatin scaffolds. The
use of HA thus not only enhances the mechanical strength
of the scaffold, but it also plays a role in cell differentiation
and tissue formation.
The most widely used method to induce cell differentia-
tion is the delivery of growth factors from scaffolds. A
variety of methods have been developed to incorporate
growth factors into scaffolds.[11,104] For example, recombi-
nant human bone morphogenic protein 7 (rhBMP-7) was
encapsulated in PLGA microspheres using a double emul-
sion technique, and the microspheres were incorporated
onto the surface of a nano-fibrous PLLA scaffold.[105] The
biomimetic PLLA scaffolds incorporated with rhBMP-7
microspheres were found to significantly enhance bone
formation. After 6 weeks of subcutaneous implantation in
Sprague-Dawley rats, the scaffolds with rhBMP-7 micro-im www.MaterialsViews.com
Figure 3. SEM images of PLLA scaffolds 4 weeks after cell seeding:
(a) PLLA controls; (b) surface-modified PLLA scaffolds. The scaffold
was physically entrapped with gelatin, followed by chemical
crosslinking; (c) high magnification of (b). Significantly higher
amount of collagen fibers and other cell secretions were depos-
ited on the surface-modified scaffolds than on the control scaf-
folds. From Liu et al.,[94] 2005 by Wiley Periodicals, Inc.
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www.mbs-journal.despheres showed significantly more bone formation than
scaffolds with rhBMP-7 simply adsorbed on the surface.
This study illustrates the important role thatgrowth factors
can play in a tissue engineering strategy.
While the most common method is to use growth
factors to induce differentiation and tissue neogenesis,www.MaterialsViews.com
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cell/matrix interactions. Recent work has shown that the
fate of human MSCs could be changed when they were
seeded on hydrogels with various functional groups.[106]
Carboxylic acid groups, mimicking cartilage glycosamino-
glycans, increased the expression of aggrecan, an indicator
of chondrogenic differentiation. Phosphate groups, impor-
tant formineralized tissue formation, increased expression
levels of CBFA1, a marker for osteogenic differentiation.
Finally, t-butyl groups, mimicking lipid filled adipocytes,
increased expression of peroxisome proliferating antigen
receptor gamma (PPARG), a measure of adipogenic
differentiation. The ability of small molecules to induce
differentiation shows potential as an easier, cheaper, and
safer way to guide the fate of stem cells, yet more work
needs to be done to validate their efficacy when compared
to the use of growth factors.5. Conclusion
The development of tissue engineering has entered a new
phase in which rational design is being used to produce
functionalized biomaterials and scaffolds tailored to
specific applications. These functionalized scaffolds are
no longer justaphysical environmentwith littleornoeffect
on the regeneration process. Rather, they are active
participants in the tissue neogenesis process.
Future research will continue to increase the active
role of the scaffold in the regeneration process and to
elucidate the mechanisms in which functionalized scaf-
folds influence cell differentiation, proliferation, and
morphology. The polymer synthesis, scaffold fabrication,
surface functionalization, and growth factor delivery could
be combined to create more advanced scaffolds tailored to
specific applications.Received: November 17, 2011; Published online: March 6, 2012;
DOI: 10.1002/mabi.201100466
Keywords: biodegradable polymers; cell adhesion; scaffolds;
surface modification; tissue engineering[1] R. Langer, J. P. Vacanti, Science 1993, 260, 920.
[2] P. X. Ma, Adv. Drug Delivery Rev. 2008, 60, 184.
[3] X. H. Liu, P. X. Ma, Ann. Biomed. Eng. 2004, 32, 477.
[4] R. Langer, D. A. Tirrell, Nature 2004, 428, 487.
[5] J. Kohn, Nat. Mater. 2004, 3, 745.
[6] J. A. Hubbell, Curr. Opin. Biotechnol. 1999, 10, 123.
[7] M. P. Lutolf, J. A. Hubbell, Nat. Biotechnol. 2005, 23, 47.
[8] L. Moroni, P. Habibovic, D. J. Mooney, C. A. van Blitterswijk,
MRS Bull. 2010, 35, 584.
[9] M. Niinomi, J. Artif. Org. 2008, 11, 105.
[10] C. Ohtsuko, M. Kamitakahara, T. Miyazaki, J. R. Soc. Interface
2009, 6, S349.12, 12, 911–919
H & Co. KGaA, Weinheim 917
918
www.mbs-journal.de
X. Liu, J. M. Holzwarth, P. X. Ma[11] G. Wei, P. X. Ma, Adv. Funct. Mater. 2008, 18, 3568.
[12] K. Rezwan, Q. Z. Chen, J. J. Blaker, A. R. Boccaccini, Biomater-
ials 2006, 27, 3413.
[13] S. F. Yang, K. F. Leong, Z. H. Du, C. K. Chua, Tissue Eng. 2002,
8, 1.
[14] S. F. Yang, K. F. Leong, Z. H. Du, C. K. Chua, Tissue Eng. 2001, 7,
679.
[15] L. A. Smith, X. H. Liu, P. X. Ma, Soft Matter 2008, 4, 2144.
[16] C. M. Agrawal, R. B. Ray, J. Biomed. Mater. Res. 2001, 55, 141.
[17] J. K. Tessmar, A. M. Gopferich, Adv. Drug Delivery Rev. 2007,
59, 274.
[18] M. J. Whitaker, R. A. Quirk, S. M. Howdle, K. M. Shakesheff,
J. Pharm. Pharmacol. 2001, 53, 1427.
[19] P. X. Ma, J. W. Choi, Tissue Eng. 2001, 7, 23.
[20] P. X. Ma, R. Y. Zhang, J. Biomed. Mater. Res. 1999, 46, 60.
[21] K. M. Woo, V. J. Chen, P. X. Ma, J. Biomed. Mater. Res., Part A
2003, 67A, 531.
[22] K. M. Woo, J. Seo, R. Y. Zhang, P. X. Ma, Biomaterials 2007, 28,
2622.
[23] L. S. Nair, C. T. Laurencin, Prog. Polym. Sci. 2007, 32, 762.
[24] B. He, J. Z. Bei, S. G. Wang, Polymer 2003, 44, 989.
[25] M. Leemhuis, C. F. vanNostrum, J. A.W. Kruijtzer, Z. Y. Zhong,
M. R. ten Breteler, P. J. Dijkstra, J. Feijen, W. E. Hennink,
Macromolecules 2006, 39, 3500.
[26] D. E. Noga, T. A. Petrie, A. Kumar, M. Weck, A. J. Garcia, D. M.
Collard, Biomacromolecules 2008, 9, 2056.
[27] W. Chen, H. C. Yang, R.Wang, R. Cheng, F. H.Meng,W. X.Wei,
Z. Y. Zhong, Macromolecules 2010, 43, 201.
[28] Y. Kimura, K. Shirotani, H. Yamane, T. Kitao, Polymer 1993,
34, 1741.
[29] Y. Kimura, K. Shirotani, H. Yamane, T. Kitao,Macromolecules
1988, 21, 3338.
[30] D. A. Barrera, E. Zylstra, P. T. Lansbury, R. Langer, J. Am. Chem.
Soc. 1993, 115, 11010.
[31] A. D. Cook, J. S. Hrkach, N. N. Gao, I. M. Johnson, U. B. Pajvani,
S. M. Cannizzaro, R. Langer, J. Biomed. Mater. Res. 1997, 35,
513.
[32] C. Deng, H. Y. Tian, P. B. Zhang, J. Sun, X. S. Chen, X. B. Jing,
Biomacromolecules 2006, 7, 590.
[33] B. Jeong, Y. H. Bae, S. W. Kim,Macromolecules 1999, 32, 7064.
[34] F. Unger, M. Wittmar, T. Kissel, Biomaterials 2007, 28, 1610.
[35] U. Westedt, M. Wittmar, M. Hellwig, P. Hanefeld, A. Greiner,
A. K. Schaper, T. Kissel, J. Controlled Release 2006, 111, 235.
[36] Y. Q. Wang, D. E. Noga, K. Yoon, A. M. Wojtowicz, A. S. P. Lin,
A. J. Garcia, D. M. Collard, M. Weck, Adv. Funct. Mater. 2008,
18, 3638.
[37] F. F. Wolf, N. Friedemann, H. Frey,Macromolecules 2009, 42,
5622.
[38] F. K. Wolf, H. Frey, Macromolecules 2009, 42, 9443.
[39] X. H. Chen, S. P. McCarthy, R. A. Gross,Macromolecules 1997,
30, 4295.
[40] C. Deng, G. Z. Rong, H. Y. Tian, Z. H. Tang, X. S. Chen, X. B. Jing,
Polymer 2005, 46, 653.
[41] T. Fujiwara, T. Mukose, T. Yamaoka, H. Yamane, S. Sakurai,
Y. Kimura, Macromol. Biosci. 2001, 1, 204.
[42] S. M. Li, M. Vert, Macromolecules 2003, 36, 8008.
[43] I. Rashkov, N. Manolova, S. M. Li, J. L. Espartero, M. Vert,
Macromolecules 1996, 29, 50.
[44] Y. Q. Wan, W. N. Chen, J. Yang, J. Z. Bei, S. G. Wang,
Biomaterials 2003, 24, 2195.
[45] Y. N. Yang, J. Cai, X. L. Zhuang, Z. P. Guo, X. B. Jing, X. S. Chen,
Polymer 2010, 51, 2676.
[46] Y. X. Li, J. Nothnagel, T. Kissel, Polymer 1997, 38, 6197.Macromol. Biosci. 20
 2012 WILEY-VCH Verlag Gmb[47] C. Nouvel, P. Dubois, E. Dellacherie, J. L. Six, J. Polym. Sci., Part
A: Polym. Chem. 2004, 42, 2577.
[48] F. S. Palumbo, G. Pitarresi, D. Mandracchia, G. Tripodo,
G. Giammona, Carbohydr. Polym. 2006, 66, 379.
[49] Y. Teramoto, Y. Nishio, Polymer 2003, 44, 2701.
[50] Y. Li, Q. B. Li, F. X. Li, H. Y. Zhang, L. Jia, J. Y. Yu, Q. Fang, A. Cao,
Biomacromolecules 2006, 7, 224.
[51] X. H. Liu, P. X. Ma, Biomaterials 2010, 31, 259.
[52] R. Riva, S. Lenoir, R. Jerome, P. Lecomte, Polymer 2005, 46,
8511.
[53] J. Rieger, K. Van Butsele, P. Lecomte, C. Detrembleur,
R. Jerome, C. Jerome, Chem. Commun. 2005, 274.
[54] C. Detrembleur, M. Mazza, O. Halleux, P. Lecomte,
D. Mecerreyes, J. L. Hedrick, R. Jerome, Macromolecules
2000, 33, 14.
[55] S. Gautier, V. D’Aloia, O. Halleux, M. Mazza, P. Lecomte,
R. Jerome, J. Biomater. Sci. -Polym. Ed. 2003, 14, 63.
[56] X. L. Hu, X. S. Chen, Z. G. Xie, H. B. Cheng, X. B. Jing, J. Polym.
Sci., Part A: Polym. Chem. 2008, 46, 7022.
[57] D. Tian, P. Dubois, C. Grandfils, R. Jerome, Macromolecules
1997, 30, 406.
[58] G. Q. Chen, Q. Wu, Biomaterials 2005, 26, 6565.
[59] J. P. Santerre, K. Woodhouse, G. Laroche, R. S. Labow, Bio-
materials 2005, 26, 7457.
[60] J. J. Guan, K. L. Fujimoto, M. S. Sacks, W. R. Wagner, Bio-
materials 2005, 26, 3961.
[61] S. J. Lee, J. S. Choi, K. S. Park, G. Khang, Y. M. Lee, H. B. Lee,
Biomaterials 2004, 25, 4699.
[62] J. Heller, J. Barr, S. Y. Ng, K. S. Abdellauoi, R. Gurny, Adv. Drug
Delivery Rev. 2002, 54, 1015.
[63] J. P. Fisher, J. W. M. Vehof, D. Dean, J. van der Waerden, T. A.
Holland, A. G. Mikos, J. A. Jansen, J. Biomed. Mater. Res. 2002,
59, 547.
[64] M. T. Conconi, S. Lora, A. M. Menti, P. Carampin, P. P. Parni-
gotto, Tissue Eng. 2006, 12, 811.
[65] X. L. Hu, S. Liu, X. S. Chen, G. J. Mo, Z. G. Xie, X. B. Jing,
Biomacromolecules 2008, 9, 553.
[66] R. Wu, T. F. Al-Azemi, K. S. Bisht, Biomacromolecules 2008, 9,
2921.
[67] Y. Zhou, R. X. Zhuo, Z. L. Liu,Macromol. Rapid Commun. 2005,
26, 1309.
[68] S. G. Zhang, Nat. Biotechnol. 2003, 21, 1171.
[69] J. D. Hartgerink, E. Beniash, S. I. Stupp, Science 2001, 294,
1684.
[70] J. D. Hartgerink, E. Beniash, S. I. Stupp, Proc. Natl. Acad. Sci.
USA 2002, 99, 5133.
[71] M. P. Lutolf, J. L. Lauer-Fields, H. G. Schmoekel, A. T. Metters,
F. E.Weber, G. B. Fields, J. A. Hubbell, Proc. Natl. Acad. Sci. USA
2003, 100, 5413.
[72] M. P. Lutolf, G. P. Raeber, A. H. Zisch, N. Tirelli, J. A. Hubbell,
Adv. Mater. 2003, 15, 888.
[73] Z. W. Ma, C. Y. Gao, Y. H. Gong, J. C. Shen, Biomaterials 2005,
26, 1253.
[74] Z. W. Ma, W. He, T. Yong, S. Ramakrishna, Tissue Eng. 2005,
11, 1149.
[75] L. Y. Santiago, R. W. Nowak, J. P. Rubin, K. G. Marra, Bio-
materials 2006, 27, 2962.
[76] J. Yang, G. X. Shi, J. Z. Bei, S. G. Wang, Y. L. Cao, Q. X. Shang,
G. G. Yang, W. J. Wang, J. Biomed. Mater. Res. 2002, 62, 438.
[77] J. J. Yoon, S. H. Song, D. S. Lee, T. G. Park, Biomaterials 2004,
25, 5613.
[78] X. B. Yang, H. I. Roach, N. M. P. Clarke, S. M. Howdle, R. Quirk,
K. M. Shakesheff, R. O. C. Oreffo, Bone 2001, 29, 523.12, 12, 911–919
H & Co. KGaA, Weinheim www.MaterialsViews.com
Functionalized Synthetic Biodegradable Polymer Scaffolds . . .
www.mbs-journal.de[79] J. M. Gao, L. Niklason, R. Langer, J. Biomed. Mater. Res. 1998,
42, 417.
[80] K. Y. Cai, K. D. Yao, X. Hou, Y. Q. Wang, Y. J. Hou, Z. M. Yang,
X. Q. Li, H. Q. Xie, J. Biomed. Mater. Res. 2002, 62, 283.
[81] T. I. Croll, A. J. O’Connor, G. W. Stevens, J. J. Cooper-White,
Biomacromolecules 2004, 5, 463.
[82] K. Y. Cai, K. D. Yao, Y. L. Cui, S. B. Lin, Z. M. Yang, X. Q. Li,
H. Q. Xie, T. W. Qing, J. Luo, J. Biomed. Mater. Res. 2002, 60,
398.
[83] M. E. Alf, A. Asatekin, M. C. Barr, S. H. Baxamusa, H. Chelawat,
G. Ozaydin-Ince, C. D. Petruczok, R. Sreenivasan,W. E. Tenhaeff,
N. J. Trujillo, S. Vaddiraju, J. J. Xu, K. K. Gleason, Adv. Mater.
2010, 22, 1993.
[84] M. L. Ma, Y. Mao, M. Gupta, K. K. Gleason, G. C. Rutledge,
Macromolecules 2005, 38, 9742.
[85] M. Leskela, H. Molsa, L. Niinisto, Supercond. Sci. Technol.
1993, 6, 627.
[86] J. Lahann, M. Balcells, T. Rodon, J. Lee, I. S. Choi, K. F. Jensen,
R. Langer, Langmuir 2002, 18, 3632.
[87] W. W. Hu, Y. Elkasabi, H. Y. Chen, Y. Zhang, J. Lahann, S. J.
Hollister, P. H. Krebsbach, Biomaterials 2009, 30, 5785.
[88] Y. Zhang, X. P. Deng, E. L. Scheller, T. G. Kwon, J. Lahann,
R. T. Franceschi, P. H. Krebsbach, Biomaterials 2010, 31,
3231.
[89] Y. Q. Wang, X. Qu, J. Lu, C. F. Zhu, L. J. Wan, J. L. Yang, J. Z. Bei,
S. G. Wang, Biomaterials 2004, 25, 4777.
[90] J. Yang, J. Z. Bei, S. G. Wang, Biomaterials 2002, 23, 2607.
[91] P. K. Chu, J. Y. Chen, L. P. Wang, N. Huang, Mater. Sci. Eng.
R-Rep. 2002, 36, 143.www.MaterialsViews.com
Macromol. Biosci. 20
 2012 WILEY-VCH Verlag Gmb[92] M. Nitschke, G. Schmack, A. Janke, F. Simon, D. Pleul,
C. Werner, J. Biomed. Mater. Res. 2002, 59, 632.
[93] Z. Y. Cheng, S. H. Teoh, Biomaterials 2004, 25, 1991.
[94] X. H. Liu, Y. J. Won, P. X. Ma, J. Biomed. Mater. Res., Part A
2005, 74A, 84.
[95] X. H. Liu, Y. J. Won, P. X. Ma, Biomaterials 2006, 27, 3980.
[96] X. H. Liu, L. Smith, G. B. Wei, Y. J. Won, P. X. Ma, J. Biomed.
Nanotechnol. 2005, 1, 54.
[97] X. Liu, L. A. Smith, J. Hu, P. X. Ma, Biomaterials 2009, 30, 2252.
[98] G. Decher, Science 1997, 277, 1232.
[99] K. Park, Y. M. Ju, J. S. Son, K.-D. Ahn, D. K. Han, J. Biomater.
Sci. -Polym. Ed. 2007, 18, 369.
[100] P. X. Ma, R. Y. Zhang, G. Z. Xiao, R. Franceschi, J. Biomed.
Mater. Res. 2001, 54, 284.
[101] U. Hersel, C. Dahmen, H. Kessler, Biomaterials 2003, 24,
4385.
[102] M. D. Pierschbacher, E. Ruoslahti, Nature 1984, 309, 30.
[103] H. Zhang, S. Hollister, J. Biomater. Sci. 2009, 20, 1975.
[104] J. E. Babensee, L. V. McIntire, A. G. Mikos, Pharm. Res. 2000,
17, 497.
[105] G. Wei, Q. Jin, W. V. Giannobile, P. X. Ma, Biomaterials 2007,
28, 2087.
[106] D. S. W. Benoit, M. P. Schwartz, A. R. Durney, K. S. Anseth,
Nat. Mater. 2008, 7, 816.
[107] X. Liu, I. O. Smith, P. X. Ma, ‘‘Biomimetic Nanophase
Materials to Promote New Tissue Formation for Tissue-
engineering Applications’’, in Biological Interactions on
Materials Surfaces, Eds., D. A. Puleo, R. Bizios), Springer,
New York 2009, pp. 283–296.12, 12, 911–919
H & Co. KGaA, Weinheim 919
